Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction 
Company name: Ceva Animal Health Ltd
Address: 90 The Broadway
Chesham
Buckinghamshire
HP5 1EG
Telephone: 01494 781510
Fax: 01494 781519
Email: cevauk@ceva.com
Website: www.ceva.com
Presentation
Cross-scored film-coated tablets, divisible into quarters by means of a groove to facilitate accurate dosage, for oral administration to dogs. Each tablet contains 4, 10 or 20 mg (-) selegiline hydrochloride.
Uses
Selegiline hydrochloride is an inhibitor of monoamine oxidase (IMAO type B) at the therapeutic dose in the dog; thus it modifies the concentration of monoaminergic neurotransmitters.
It is indicated for use as follows:
1.Treatment of behavioural disorders of purely emotional origin : depression, anxiety.
2.In association with behaviour therapy, treatment of signs of emotional origin observed in behavioural conditions such as overactivity, separation problems, generalised phobia and unsocial behaviour.
Emotional disorders are characterised by a modification of feeding, drinking, auto-stimulatory behaviour, sleep, exploratory behaviour, aggression related to fear and/or irritation, social behaviour and somatic disorders (tachycardia, emotional micturition).
Dosage and administration
For oral administration to dogs. The dose rate is 0.5 mg/kg/day (-) selegiline hydrochloride in a single administration.
Dog weight in kg
Selgian 4
| Number of tablets
| ≥1.5
| <3
| ¼
| ≥3
| <5
| ½
| ≥5
| <7
| ¾
| ≥7
| <9
| 1
| ≥9
| <11
| 1-¼
| ≥11
| <13
| 1-½
| ≥13
| <15
| 1-¾
| ≥15
Selgian 10
≥8
≥12
≥17
≥22
≥27
≥32
≥37
Selgian 20
≥26
≥36
≥46
≥56
≥66
≥76
| <17
.
<12
<17
<22
<27
<32
<37
<42
.
<36
<46
<56
<66
<76
<86
| 2
.
½
¾
1
1-¼
1-½
1-¾
2
.
¾
1
1-¼
1-½
1-¾
2
|
For dogs weighing less than 8 kg, the use of Selgian® 4 mg is advisable. For dogs weighing more than 17 kg, the use of Selgian® 10 mg or Selgian® 20 mg is advisable. For dogs weighing less than 26 kg, the use of Selgian® 4 mg or 10 mg is advisable.
The treatment should be continued until the clinical condition is stable.
The minimum treatment period recommended is 2 months, based on the clinical trials results:
The treatment period was 2-3 months for 20% of the dogs.
The treatment period was 4-5 months for 50% of the dogs.
The treatment period was 6-7 months for 20% of the dogs.
The treatment period was >7 months for 10% of the dogs.
The treatment can be stopped suddenly without gradual dose reductions.
Contra-indications, warnings, etc
Owing to its IMAO properties, (-) selegiline hydrochloride may act on prolactin secretion. In the absence of specific studies, it is recommended that Selgian® should not be administered to pregnant and lactating bitches.
Selgian® should not be administered from the day before until the day after anaesthesia or tranquillisation performed with an alpha-2 agonist.
Do not administer with other alpha-2 agonists.
Selgian® should not be administered concomitantly with pethidine, fluoxetine or phenothiazines. The narcotic action of morphine is potentiated by Selgian®.
Emotional disorders can mask hierarchical conflicts. In dominant dogs suffering from an emotional disorder, the alleviation of the disorder can sometimes reveal a latent aggressiveness. In such cases, behavioural therapy must be instituted.
It is recommended to stop the treatment during pregnancy and lactation.
If no clinical improvement is observed after 2 months, continuing the treatment is unlikely to provide any further benefit. It is advisable to weigh animals before dosing to ensure the correct mg/kg dosage is administered.
Special precautions to be taken by the person administering the medicinal product to animals
In the event of accidental ingestion, seek medical advice and show the doctor the package leaflet. Wash hands after use.
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements.
For animal treatment only. Keep out of reach and sight of children.
Pharmaceutical precautions
Store below 25°C. The tablets are divisible into quarters. Tablet portions can be kept for 4 days in the blister pack.
Legal category
POM-V
Packaging Quantities
Box containing 3 blisters of 10 tablets.
Box containing 10 blisters of 10 tablets (for Selgian 10 mg only)
Further information
Nil.
Marketing authorisation number
Vm 14966/4000.
Vm 14966/4001.
Vm 14966/4004.
| 
